These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1216 related items for PubMed ID: 17128669

  • 21. [Multiple sclerosis: imaging, diagnostic criteria and differential diagnosis].
    Harting I, Sellner J, Meyding-Lamadé U, Sartor K.
    Rofo; 2003 May; 175(5):613-22. PubMed ID: 12743852
    [Abstract] [Full Text] [Related]

  • 22. [Contribution of nuclear magnetic resonance imaging in multiple sclerosis].
    Ranjeva JP, Audoin B, Pelletier J, Confavreux C.
    Rev Prat; 2006 Jun 30; 56(12):1326-35. PubMed ID: 16948221
    [Abstract] [Full Text] [Related]

  • 23. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A, Toledo EG, Alexander JS, Kelley RE.
    J Neuroimaging; 2004 Jul 30; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [Abstract] [Full Text] [Related]

  • 24. [In-vivo assessment of multiple sclerosis pathology: the role of neuroimaging techniques].
    Comi G, Rovaris M, Filippi M.
    Rev Neurol; 2004 Jul 30; 30(12):1218-23. PubMed ID: 10935254
    [Abstract] [Full Text] [Related]

  • 25. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.
    Inglese M, Grossman RI, Filippi M.
    J Neuroimaging; 2005 Jul 30; 15(4 Suppl):22S-29S. PubMed ID: 16385016
    [Abstract] [Full Text] [Related]

  • 26. Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis.
    Gallo A, Rovaris M, Riva R, Ghezzi A, Benedetti B, Martinelli V, Falini A, Comi G, Filippi M.
    Arch Neurol; 2005 May 30; 62(5):803-8. PubMed ID: 15883269
    [Abstract] [Full Text] [Related]

  • 27. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
    Vrenken H, Geurts JJ.
    Expert Rev Neurother; 2007 Mar 30; 7(3):271-9. PubMed ID: 17341175
    [Abstract] [Full Text] [Related]

  • 28. MRI relapses have significant pathologic and clinical implications in multiple sclerosis.
    Traboulsee A.
    J Neurol Sci; 2007 May 15; 256 Suppl 1():S19-22. PubMed ID: 17346748
    [Abstract] [Full Text] [Related]

  • 29. Magnetisation transfer imaging in multiple sclerosis.
    Filippi M, Rovaris M.
    J Neurovirol; 2000 May 15; 6 Suppl 2():S115-20. PubMed ID: 10871798
    [Abstract] [Full Text] [Related]

  • 30. Gadofluorine M enhancement allows more sensitive detection of inflammatory CNS lesions than T2-w imaging: a quantitative MRI study.
    Bendszus M, Ladewig G, Jestaedt L, Misselwitz B, Solymosi L, Toyka K, Stoll G.
    Brain; 2008 Sep 15; 131(Pt 9):2341-52. PubMed ID: 18669504
    [Abstract] [Full Text] [Related]

  • 31. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.
    Minneboo A, Barkhof F, Polman CH, Uitdehaag BM, Knol DL, Castelijns JA.
    Arch Neurol; 2004 Feb 15; 61(2):217-21. PubMed ID: 14967769
    [Abstract] [Full Text] [Related]

  • 32. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.
    Mult Scler; 2009 Feb 15; 15(2):204-11. PubMed ID: 18987104
    [Abstract] [Full Text] [Related]

  • 33. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis.
    Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF.
    Ann Neurol; 1993 Nov 15; 34(5):661-9. PubMed ID: 8239560
    [Abstract] [Full Text] [Related]

  • 34. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
    De Stefano N, Battaglini M, Stromillo ML, Zipoli V, Bartolozzi ML, Guidi L, Siracusa G, Portaccio E, Giorgio A, Sorbi S, Federico A, Amato MP.
    Brain; 2006 Aug 15; 129(Pt 8):2008-16. PubMed ID: 16815879
    [Abstract] [Full Text] [Related]

  • 35. Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics.
    Leist TP, Marks S.
    Neurology; 2010 Jan 05; 74 Suppl 1():S54-61. PubMed ID: 20038764
    [Abstract] [Full Text] [Related]

  • 36. [New imaging methods by nuclear magnetic resonance in multiple sclerosis].
    Mekies C, Berry I, Manelfe C, Clanet M.
    Rev Prat; 1991 Sep 15; 41(20):1908-12. PubMed ID: 1925375
    [Abstract] [Full Text] [Related]

  • 37. [Magnetic resonance and multiple sclerosis II. New diagnostic techniques].
    Mathiesen HK, Langkilde AR, Larsson HB.
    Ugeskr Laeger; 2002 Feb 18; 164(8):1031-6. PubMed ID: 11894703
    [Abstract] [Full Text] [Related]

  • 38. Magnetic resonance imaging surrogates of multiple sclerosis pathology and their relationship to central nervous system atrophy.
    Meier DS, Weiner HL, Khoury SJ, Guttmann CR.
    J Neuroimaging; 2004 Jul 18; 14(3 Suppl):46S-53S. PubMed ID: 15228759
    [Abstract] [Full Text] [Related]

  • 39. Magnetic resonance imaging in multiple sclerosis.
    Napoli SQ, Bakshi R.
    Rev Neurol Dis; 2005 Jul 18; 2(3):109-16. PubMed ID: 16400309
    [Abstract] [Full Text] [Related]

  • 40. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
    Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, Lublin FD, Paty DW, Reingold SC, Simon J.
    Ann Neurol; 1996 Jan 18; 39(1):6-16. PubMed ID: 8572668
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.